Ubs Group Ag Haemonetics Corp Transaction History

Ubs Group Ag

$397 Billion
Q1 2024

A detailed history of Ubs Group Ag transactions in Haemonetics Corp stock. As of the latest transaction made, Ubs Group Ag holds 58,114 shares of HAE stock, worth $4.89 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

58,114

Previous 72,087 19.38%

Holding current value

$4.89 Million

Previous $6.16 Million 19.53%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$71.24 - $85.35 $995,436 - $1.19 Million	-13,973 Reduced 19.38%	58,114 $4.96 Million
Q4 2023 Feb 09, 2024	BUY	$80.59 - $92.61 $2.23 Million - $2.56 Million	27,618 Added 62.11%	72,087 $6.16 Million
Q3 2023 Nov 09, 2023	SELL	$82.56 - $93.49 $2.1 Million - $2.37 Million	-25,399 Reduced 36.35%	44,469 $3.98 Million
Q2 2023 Aug 11, 2023	BUY	$80.84 - $89.45 $893,767 - $988,959	11,056 Added 18.8%	69,868 $5.95 Million
Q1 2023 May 12, 2023	BUY	$72.75 - $90.6 $1.13 Million - $1.41 Million	15,563 Added 35.98%	58,812 $4.87 Million

Q4 2022 Feb 08, 2023	BUY	$73.85 - $86.14 $2.75 Million - $3.21 Million	37,274 Added 623.83%	43,249 $3.4 Million
Q3 2022 Nov 10, 2022	BUY	$63.3 - $78.66 $58,172 - $72,288	919 Added 18.18%	5,975 $442,000
Q2 2022 Aug 10, 2022	SELL	$49.27 - $66.08 $729,196 - $977,984	-14,800 Reduced 74.54%	5,056 $329,000
Q1 2022 May 16, 2022	SELL	$43.77 - $63.22 $594,527 - $858,717	-13,583 Reduced 40.62%	19,856 $1.26 Million
Q4 2021 Feb 14, 2022	BUY	$49.55 - $74.59 $1.49 Million - $2.24 Million	30,020 Added 878.03%	33,439 $1.77 Million
Q3 2021 Nov 15, 2021	SELL	$57.6 - $70.59 $15,840 - $19,412	-275 Reduced 7.44%	3,419 $241,000
Q2 2021 Aug 13, 2021	SELL	$51.81 - $118.56 $747,773 - $1.71 Million	-14,433 Reduced 79.62%	3,694 $246,000
Q1 2021 May 12, 2021	SELL	$111.01 - $139.48 $585,688 - $735,896	-5,276 Reduced 22.54%	18,127 $2.01 Million
Q4 2020 Feb 11, 2021	SELL	$88.75 - $119.95 $1.17 Million - $1.58 Million	-13,209 Reduced 36.08%	23,403 $2.78 Million
Q3 2020 Nov 12, 2020	BUY	$75.65 - $93.58 $2.34 Million - $2.89 Million	30,890 Added 539.85%	36,612 $3.19 Million
Q2 2020 Jul 31, 2020	SELL	$84.96 - $118.91 $492,088 - $688,726	-5,792 Reduced 50.3%	5,722 $512,000
Q1 2020 May 01, 2020	SELL	$74.34 - $121.82 $7.79 Million - $12.8 Million	-104,784 Reduced 90.1%	11,514 $1.15 Million
Q4 2019 Feb 14, 2020	BUY	$114.37 - $129.46 $6.97 Million - $7.88 Million	60,904 Added 109.95%	116,298 $13.4 Million
Q3 2019 Nov 14, 2019	BUY	$117.16 - $138.52 $3.11 Million - $3.68 Million	26,586 Added 92.29%	55,394 $6.99 Million
Q2 2019 Aug 14, 2019	SELL	$81.74 - $120.34 $834,565 - $1.23 Million	-10,210 Reduced 26.17%	28,808 $3.47 Million
Q1 2019 May 14, 2019	SELL	$83.25 - $102.12 $1.68 Million - $2.07 Million	-20,231 Reduced 34.15%	39,018 $3.41 Million
Q4 2018 Feb 14, 2019	SELL	$90.66 - $116.63 $225,199 - $289,708	-2,484 Reduced 4.02%	59,249 $5.93 Million
Q3 2018 Nov 14, 2018	BUY	$89.96 - $114.58 $2.43 Million - $3.09 Million	26,961 Added 77.54%	61,733 $7.07 Million
Q2 2018 Aug 14, 2018	BUY	$71.53 - $95.75 $1.46 Million - $1.95 Million	20,376 Added 141.54%	34,772 $3.12 Million
Q1 2018 May 15, 2018	BUY	$60.72 - $74.41 $132,673 - $162,585	2,185 Added 17.89%	14,396 $1.05 Million
Q4 2017 Feb 14, 2018	SELL	$44.96 - $58.99 $183,661 - $240,974	-4,085 Reduced 25.07%	12,211 $709,000
Q3 2017 Nov 14, 2017	BUY	$40.38 - $44.87 $194,389 - $216,004	4,814 Added 41.93%	16,296 $731,000
Q2 2017 Aug 14, 2017	SELL	N/A	-1,230 Reduced 9.68%	11,482 $453,000
Q1 2017 Nov 14, 2017	BUY	N/A	12,712	12,712 $516,000

Others Institutions Holding HAE

# of Institutions

310

Shares Held

50.1M

Call Options Held

161K

Put Options Held

56.3K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.32B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account